Visit
www.asippannualmeeting.com
for more details. We will update this site frequently with new information as it becomes available.
Visit this site for information on our refund policy.
|
|
ASIPP WEBINAR-BASED VIRTUAL EDUCATION
Registration Now!
|
|
ASIPP Virtual Review Courses – Informative, Convenient,
and Cost-effective
On June 13-14 ASIPP held our first virtual review course. The Documentation, Coding, Compliance, and Practice Management course was a huge success!
Up next is the ASIPP Controlled Substance Management course. This
2-day course
will provide 20 CME credits, 22 exciting lectures, and 16 expert presenters. All of this in the comfort and convenience of your own home! No travel! No hotels! - Just you and your computer or smart device in the viewing setting of your choice.
This course fulfills the various state board requirement for controlled substance CMEs and is relevant to all specialties, not just IPM.
We offer discounts to our already reasonably priced meetings to ASIPP members, residents/fellows ($50), and medical students ($10).
Click here for full pricing
|
|
REGISTRATION OPEN
(Note* This course takes place over two weekends (Friday evening through Sunday) in order to fulfill the necessary topics)
|
|
ABIPP Recognizes Your Knowledge and Expertise
The
American Board of Interventional Pain Physicians
(
ABIPP
)
has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become
ABIPP
certified.
ABIPP
now offers the only competency
certification program for regenerative medicine.
|
|
DATES
ABIPP Part I
- Theoretical written exam - October 3
ABIPP Part II
- Oral and Hands-on practical exam - October 3-4
ABIPP Competency Exam
- includes written, oral, and hands-on practical examinations October 3-4
Combined CSM/CCPM Exam for ABIPP Path
– October 3
Competency Exam in Controlled Substance Management
– October 3
Competency Exam in Coding, Compliance, and Practice Management
- October 3
Regenerative Medicine Competency Exam
- includes written, oral, and hands-on practical examinations – October 3-4
|
|
|
For complete information about the examination requirements and to obtain an application packet, visit
www.abipp.org
or call 270-554-9412 x4217 or by email at
summer@asipp.org
.
|
|
May/June 2020 Issue Available
|
In this issue,
Pain Physician
includes randomized trials on cervical plexus blocks for endarterectomy, pulsed radiofrequency for hemiplegic shouldr pain, ultrasound-guided injection for meralgia paresthetica, and more.
|
|
|
Randomized Trial
Emiliano Petrucci, MD, Vincenza Cofini, MD, Barbara Pizzi, MD, Rosaria Coletta, MD, Angelo Geremia Blasetti, MD, Stefano Necozione, MD, Pierfrancesco Fusco, MD, and Franco Marinangeli, MD.
Randomized Trial
Ebru Alanbay, MD, Berke Aras, MD, Serdar Kesikburun, MD, Selvinaz Kizilirmak, MD, Evren Yasar, MD, and Arif Kenan Tan, MD.
Randomized Trial
Selda Kiliç, MD, Feyza Ünlü Özkan, MD, Duygu Geler Külcü, MD, Gülcan Öztürk, MD, Pinar Akpinar, MD, and Ilknur Aktas, MD.
Randomized Trial
Botao Liu, MD, Yang Yang, MD, Zhongyi Zhang, MD, Haining Wang, MD, Bifa Fan, MD, and Lei Sima, MD.
|
|
ASIPP's Response to CDC Proposed Revision of
Opioid Guidelines
There have been numerous changes since the CDC guidelines were first published. During this time, HHS Inter-Agency Task Force developed Pain Management Best Practices: Updates, Gaps, Inconsistencies, and Recommendations. This is an excellent document with significant importance to interventional pain management. Yesterday, ASIPP sent a letter of response to the CDC with the following requests:
1. Please utilize the Inter-Agency Task Force recommendations in its entirety for opioid prescribing, interventional techniques including neuromodulation.
2. Please postpone the final decision due to the COVID-19 pandemic.
3. Please include the practitioner community along with CMS officials.
4. Please consider and include only the systematic reviews and guidelines performed by experts in the pain management field and relevant societies developing evidence-based guidelines.
|
|
VIEW ARCHIVED WEBINARS
ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 6
ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 5
ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 4
ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 3
Surviving the COVID-19 Epidemic: Protecting Family and Employees and Managing Financial Issues and Burnout – PART 2
Surviving the Coronavirus Pandemic: Practical Advice Every Pain Physician Needs to Know – PART 1
|
|
9 Proactive Measures to Prepare Practices for Next COVID-19 Wave
|
|
As medical practices work to return to pre-COVID-19 volumes and revenues, there remains a need to plan for a potential downturn later in 2020 if a resurgence of
coronavirus forces new shutdown orders for parts of the economy or stay-at-home orders for your patient population.
Key considerations for these scenarios were recently explored in the virtual town hall, “Preparing Your Practice for COVID-19’s Second Wave,” featuring:
o
Brian Ramos, MBA, CMPE, chief operating officer, Capital Anesthesia Partners
o
Cameron Cox III, MHA, FACMPE, president and CEO, MSOC Health
o
Maddox Casey, CPA, member, Warren Averett
o
Nelson Gomes, senior vice president of development, Medicus IT
o
Nan Gallagher, JD, principal, The Nan Gallagher Law Group.
1. Money matters
2. Right-size your practice, both in staff and visitors
3. Make your providers and staff feel safe
4. Evaluate HIPAA compliance and optimize your cloud
5. Defend your practice’s online reputation while building your digital outreach
6. Ensure top-of-licensure work
7. Find talented new hires while they’re available
8. Consider your office space and options
|
|
Forecasting Severity of COVID-19 Patients Using Cortisol Levels
|
|
Patients with COVID-19 who have high levels of the steroid hormone cortisol on admission to hospital have a substantially increased risk of dying, UK researchers have discovered.
Waljit S. Dhillo, MBBS, PhD, head of the Division of Diabetes, Endocrinology and Metabolism at Imperial College London, UK, and colleagues studied 535 patients admitted to major London hospitals. Their article was
published online
June 18 in Lancet Diabetes & Endocrinology.
“Our analyses show for the first time that patients with COVID-19 mount a marked and appropriate acute cortisol stress response,” say Dhillo and colleagues.
Moreover, “high cortisol concentrations were associated with increased mortality and a reduced median survival, probably because this is a marker of the severity of illness.”
So measuring cortisol on admission is potentially “another simple marker to use alongside oxygen saturation levels to help us identify which patients need to be admitted immediately, and which may not,” Dhillo noted in a statement from his institution.
|
|
What Does Asymptomatic COVID-19 Look Like Under the Surface?
|
|
Many individuals show subclinical abnormalities as well as differences from symptomatic patients
Asymptomatic individuals carrying SARS-CoV-2 shed the virus longer than those with COVID-19 symptoms, with other lab findings suggesting the symptomatic patients mounted more robust immune responses, a small study in China found.
Median duration of viral shedding among 37 asymptomatic patients was 19 days (interquartile range 15-26; range 6-45) versus 14 days among 37 matched symptomatic patients (IQR 9-22; log-rank P=0.028), reported Jing-Fu Qiu, PhD, of Chongqing Medical University, and colleagues, though viral shedding does not necessarily mean the patients were infectious.
|
|
OTC Cough/Cold Meds Recalled Due to Incorrect Dosing Cups
|
|
GlaxoSmithKline (GSK) Consumer Healthcare announced the voluntary recall of 2 lots of Children’s Robitussin® Honey Cough and Chest Congestion DM and 1 lot of Children’s Dimetapp® Cold and Cough due to the inclusion of incorrect dosing cups.
The recalled lots were distributed nationwide between February 5, 2020 and June 3, 2020 and include:
- Children’s Robitussin Honey Cough and Chest Congestion DM; NDC 0031-8760-12; Lot 02177 (Expiration Date January 2022); Lot 02178 (Expiration Date January 2022).
- Children’s Dimetapp Cold and Cough; NDC 0031-2234-19; Lot CL8292 (Expiration Date September 2021).
|
|
ASIPP
®
Partners with Fedora Billing And Revenue Cycle
Management Company
|
|
ASIPP is now able to offer unique benefits for revenue cycle management with billing, etc.
Fedora
is a company known to many of our board members and others.
ASIPP
®
has reached an agreement with Fedora to provide exclusive discounts on billing or revenue cycle management that will decrease practice costs and promote growth, or at least stop deterioration. It is not just a billing company; they streamline the billing and receivable process and constantly update payor regulations keeping your practice up to on date on a daily basis.
Some of the
ASIPP
®
Billing Program highlights are below:
Up to 50% savings for
ASIPP
®
members for their billing or revenue cycle management for their offices and surgery centers:
- Expertise in interventional pain management billing for all types of services
- 99% Clearing House Rate
- 95% First-Time Claim Passage
- 23.4 Average Days in A/R
- Eligibility and Benefits Verification
- Pre-Certification/Prior Authorization
- Denials and A/R Management
|
|
Join The Group Purchasing Organization Today
|
|
ASIPP
®
has formed a partnership with
Henry Schein
and
PedsPal
, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value added services for the independent physician. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today. While the cost of contrast media has skyrocketed due to the single dose vial issue, because we have partnered with Henry Schein, this could enable you to purchase Omnipaque 240mg/50mL for slightly above $4.50.
It will be easy for
ASIPP
®
members in good standing to enroll today and begin to realize the savings this partnership can bring. Members can join or see sample prices by going to
http://pedspal.org/asipp/default.html
Click on “view our discounted supplier prices” (Username:ASIPPmember and Password: Save) or click on the words "join for free now" and begin saving today!
|
|
ASIPP Members Asked to Respond to Survey
|
|
Survey of Practice Parameters of Physicians Trialing and Implanting Spinal Cord Stimulators
We are asking you to take part in an online research study being done by the pain department at Beth Israel Deaconess Medical Center. This study has qualified for exempt status by the Beth Israel Deaconess Medical Center Institutional Review Board. Your participation in this survey is strictly voluntary. Note that there are no foreseeable risks associated with this study. Data will be analyzed in aggregate form and no information will be collected that could personally identify you. Importantly, your privacy will be maintained in all published and written data. The data will be stored as required by journal and professional standards.
If you choose to be in the study, you will complete an online survey. This survey will help us learn more about the practice parameters of pain physicians who perform spinal cord stimulator trials or implants.
The survey will take about 5 minutes to complete.
|
|
FDA Slaps Stem Cell Firm Linked to Nebraska Infections
|
|
EUCYT Laboratories also pushing exosome treatments for COVID-19
The agency also warned EUCYT for marketing an exosome product COVIXO that it claimed could treat COVID-19.
Paul Knoepfler, PhD, a stem cell expert at the University of California Davis,
wrote in a blog post
that the June 4 letter "is one of the more lengthy warnings that I've seen recently" as it highlights some 13 "major observations."
|
|
CMS Unveils Major Organizational Change to Reduce Provider and Clinician Burden and Improve Patient Outcomes
|
|
Today, the Centers for Medicare & Medicaid Services (CMS) is announcing the creation of the Office of Burden Reduction and Health Informatics to unify the agency’s efforts to reduce regulatory and administrative burden and to further the goal of putting patients first. The new office is an outgrowth of the agency’s Patients over Paperwork (PoP) Initiative, which is the cornerstone of CMS’s ongoing efforts to implement President Trump’s
2017 executive order to “Cut the Red Tape”
and eliminate duplicative, unnecessary, and excessively costly requirements and regulations. This announcement permanently embeds a culture of burden reduction across all platforms of CMS agency operations.
CMS’s burden reduction work began three years ago with the launch of our PoP Initiative, which has focused on reducing unnecessary regulatory burden, in order to allow providers to concentrate on their primary mission: patient care. The results are expected to save providers and clinicians $6.6 billion and 42 million unnecessary burden hours through 2021. As part of our efforts to date, CMS has heard from over 2,500 providers, clinicians, administrative staff, health care leaders, beneficiaries and their support teams through 158 site visits and listening sessions. Through more than 10 Requests for Information (RFI) combined with stakeholder interviews, CMS also has over 15,000 comments to assist us in our burden reduction efforts.
|
|
Essentials of Regenerative Medicine in Interventional
Pain Management
|
|
|
|
Essentials of Regenerative Medicine in Interventional Pain Management is a book to bring concise, collective, and comprehensive information to interventional pain physicians practicing regenerative medicine in managing chronic pain. Regenerative medicine is an integral part of interventional pain management within the definitions of interventional pain management and interventional techniques.
Each chapter contains an introduction of the subject, historical context,pathophysiology, applicability of regenerative medicine with its evidence base, indications, anatomy, technical aspects, complications, and precautions for each topic when available and applicable. This comprehensive book consists of 35 chapters, more than 350 figures, and 50 tables.
|
|
|
ORDER
|
Essentials of Regenerative Medicine in IPM
|
|
Regenerative Medicine for Spine Disease
On Demand Course covering Biologics in the treatment of DDD and Back Pain PRP, Bone Marrow Aspirate ASIPP Guidelines, Theory and Evidence Ultrasound Bone Marrow Aspirate PRP preparation. Video includes 1 CME Credit. Learn More. [
https://painexam.com/events/]
|
|
Who’s to blame? These three scientists are at the heart of the Surgisphere COVID-19 scandal
|
|
Three unlikely collaborators are at the heart of the fast-moving COVID-19 research scandal, which led to
retractions last week by The Lancet and The New England Journal of Medicine
(NEJM), and the withdrawal of an online preprint, after the trove of patient data they all relied on was challenged. The three physician-scientists never were at the same institution nor had they ever before written together, but they are the only authors in common on the disputed papers, and the other co-authors all have ties to at least one of them. Their partnership, which seized a high-impact role during a global public health crisis, has now ended disastrously.
The first author for both retracted papers was cardiac surgeon Mandeep Mehra, an eminent Harvard University professor who works at Brigham and Women’s Hospital (BWH) and is known internationally for cardiovascular medicine and heart transplants. He provided the kind of gravitas that can fast-track papers to leading journals. In a statement provided by BWH, Mehra said he had met another of the trio, cardiac surgeon Amit Patel, in “academic and medical circles,” and that Patel had introduced him to Sapan Desai, a vascular surgeon and founder of Surgisphere, the tiny company that supplied the data. Journal disclosures, however, also indicate Mehra received compensation from Triple-Gene, a gene therapy company Patel co-founded to develop cardiovascular treatments.
|
|
Control Your Waiting Room TV
Customized waiting room TV exclusively for
ASIPP
®
members. Create your own ad-free television broadcasts using our videos, custom informational slides and your own YouTube videos. Even add local weather reports, news and live messages.
|
|
|
|
|
|
GSIPP 16th Annual Pain Summit
|
|
The Ritz-Carlton Reynolds Plantation
Lake Oconee
|
|
|
|
|
|
|
2020 12th Annual Scientific
Meeting
|
|
|
|
|
|
|
|
|
|
